Search

Your search keyword '"Galleron, Nathalie"' showing total 162 results

Search Constraints

Start Over You searched for: Author "Galleron, Nathalie" Remove constraint Author: "Galleron, Nathalie"
162 results on '"Galleron, Nathalie"'

Search Results

2. Perturbation and resilience of the gut microbiome up to 3 months after β-lactams exposure in healthy volunteers suggest an important role of microbial β-lactamases

3. The gut microbiota contributes to the pathogenesis of anorexia nervosa in humans and mice

4. Alteration of Gut Microbiome in Patients With Schizophrenia Indicates Links Between Bacterial Tyrosine Biosynthesis and Cognitive Dysfunction

5. Rifaximin-α reduces gut-derived inflammation and mucin degradation in cirrhosis and encephalopathy: RIFSYS randomised controlled trial

7. Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer

8. Microbiome and metabolome features of the cardiometabolic disease spectrum

9. Combinatorial, additive and dose-dependent drug–microbiome associations

10. Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients

13. Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors

14. Extending the cereus group genomics to putative food-borne pathogens of different toxicity

15. Perturbation and resilience of the gut microbiome up to 3 months after β-lactams exposure in healthy volunteers suggest an important role of microbial β-lactamases.

16. Driving gut microbiota enterotypes through host genetics

17. Driving gut microbiota enterotypes through host genetics

18. Perturbation and resilience of the gut microbiome up to three months after β-lactams exposure in healthy volunteers suggest an important role of endogenous β-lactamases

19. Both Disease Activity and HLA–B27 Status Are Associated With Gut Microbiome Dysbiosis in Spondyloarthritis Patients

20. Impairment of gut microbial biotin metabolism and host biotin status in severe obesity: effect of biotin and prebiotic supplementation on improved metabolism

21. Rifaximin-alpha reduces gut-derived inflammation and mucin degradation in cirrhosis and encephalopathy : RIFSYS randomised controlled trial

22. Impairment of gut microbial biotin metabolism and host biotin status in severe obesity:effect of biotin and prebiotic supplementation on improved metabolism

23. Diet Supplementation with NUTRIOSE, a Resistant Dextrin, Increases the Abundance of Parabacteroides distasonis in the Human Gut

24. Increasing the diversity of dietary fibers in a daily-consumed bread modifies gut microbiota and metabolic profile in subjects at cardiometabolic risk

25. Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in advanced non-small cell lung cancer patients

26. Both Disease Activity and HLA–B27 Status Are Associated With Gut Microbiome Dysbiosis in Spondyloarthritis Patients.

27. Dietary intervention impact on gut microbial gene richness

28. Extending the Bacillus cereus group genomics to putative food-borne pathogens of different toxicity

29. Genome sequence of Bacillus cereus and comparative analysis with Bacillus anthracis

30. Statin therapy is associated with lower prevalence of gut microbiota dysbiosis

31. Organization of the Bacillus subtilis 168 chromosome between kdg and the attachment site of the SPbeta prophage: use of Long Accurate PCR and yeast artificial chromosomes for sequencing

32. Sequence analysis of the Bacillus subtilis chromosome region between the serA and kdg loci cloned in a yeast artificial chromosome

33. Two-month consumption of bread enriched with a fiber mix: impact on gut microbiota and cardiometabolic profile in at cardiometabolic-risk subjects.

34. Intestinal Akkermansia muciniphilapredicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer

35. Low FODMAP diet improves functional-like gastrointestinal symptoms but reduces bifidobacteria and faecalibacterium prausnitzii in Quiescent inflammatory bowel disease: a randomised controlled trial and metagenomic analysis

36. Low fodmap diet improves functional-like gastrointestinal symptoms but reduces bifidobacteria in quiescent inflammatory bowel disease

37. ADWE-09 Low fodmap diet improves functional-like gastrointestinal symptoms but reduces bifidobacteria in quiescent inflammatory bowel disease

38. Microbial ecology perturbation in human IgA deficiency

39. 902 - Low Fodmap Diet Improves Functional-Like Gastrointestinal Symptoms but Reduces Bifidobacteria and Faecalibacterium Prausnitzii in Quiescent Inflammatory Bowel Disease: A Randomised Controlled Trial and Metagenomic Analysis

40. The genetically remote pathogenic strain NVH391-98 of the Bacillus cereus group is representative of a cluster of thermophilic strains

41. Multiple-Locus sequence typing analysis of Bacillus cereus and Bacillus thuringiensis reveals separate clustering and a distinct population structure of psychrotrophic strains

42. Quantifying Diet-Induced Metabolic Changes of the Human Gut Microbiome

43. Characterization of the gut microbiota by quantitative metagenomics: a promising tool for risk stratification in NAFLD patients

44. Lactobacillus delbrueckii ssp. lactis and ssp. bulgaricus: a chronicle of evolution in action

45. Erratum: Corrigendum: Dietary intervention impact on gut microbial gene richness

46. The complete genome sequence of the gram-positive bacterium Bacillus subtilis

47. Bacillus cytotoxicus sp. nov. is a novel thermotolerant species of the Bacillus cereus Group occasionally associated with food poisoning

49. Specificity of insertion of Tn 1545 transposon family in Lactococcus lactis subsp. lactis

50. Complete Genome Sequence of the Commensal Streptococcus salivarius Strain JIM8777

Catalog

Books, media, physical & digital resources